Access cutting-edge epiphora treatment through this clinical trial at a research site in New Orleans. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this New Orleans location
Preparing your pre-screening questions…
Access epiphora specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related epiphora treatment provided free
Check if you qualify for this epiphora clinical trial in New Orleans, LA
No-Cost Study Care
Local to New Orleans
Convenient for LA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Purpose: It is unknown whether instillation of a drop of anesthetic ophthalmic solution into the eye such as proparacaine hydrochloride 0.5% prior to probing and irrigation of the tear duct (lacrimal drainage) system improves participant comfort during the procedure. To date, there have been no formal studies evaluating the possible benefit of this pretreatment. Methods: Participants 18 years and older who present to the Louisiana State University or associated outpatient ophthalmology clinic(s) with a complaint of epiphora (excessive tearing) who necessitate bilateral lower lid probing and irrigation of the lacrimal drainage system will be enrolled in the study. One eye will be randomized to receive a drop of the anesthetic Proparacaine hydrochloride 0.5% and the other eye will receive a control drop of Balanced Salt Solution (BSS). Probing and irrigation will then be performed in the usual fashion. The participant will then be questioned via survey on a pain scale of 1-5 as to the amount of subjective pain experienced on each side during the procedure. Expected Results: Investigators expect participants will experience statistically significantly less pain in eyes that have received a drop of Proparacaine hydrochloride 0.5% prior to performance of probing and irrigation compared to the eyes which have received the control drop.
Sponsor: Louisiana State University Health Sciences Center in New Orleans
Yes, this clinical trial (NCT05663684) has an active research site in New Orleans, LA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for epiphora treatment options in New Orleans, LA, this clinical trial (NCT05663684) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New Orleans research site is actively enrolling participants for this clinical trial. You'll receive care from experienced epiphora specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all epiphora clinical trials near you to find additional studies recruiting in your area.
See all rheumatoid arthritis clinical trials recruiting in New Orleans — not just this study.
Browse Rheumatoid Arthritis Trials in New Orleans →